Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial

Concerns about inadequate performance and complexity limit routine use of clinical risk scores in lower respiratory tract infections. Our aim was to study feasibility and effects of adding the biomarker proadrenomedullin (proADM) to the confusion, urea>7 mmol·L(-1), respiratory rate≥30 breaths·mi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The European respiratory journal 2013-10, Vol.42 (4), p.1064-1075
Hauptverfasser: ALBRICH, Werner C, RÜEGGER, Kristina, GUGLIELMETTI, Merih, CONCA, Antoinette, SCHÄFER, Petra, SCHUBERT, Maria, DE GEEST, Sabina, REUTLINGER, Barbara, IRANI, Sarosh, BÜRGI, Ulrich, HUBER, Andreas, MÜLLER, Beat, DUSEMUND, Frank, SCHUETZ, Philipp, ARICI, Birsen, LITKE, Alexander, BLUM, Claudine A, BOSSART, Rita, REGEZ, Katharina, SCHILD, Ursula
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Concerns about inadequate performance and complexity limit routine use of clinical risk scores in lower respiratory tract infections. Our aim was to study feasibility and effects of adding the biomarker proadrenomedullin (proADM) to the confusion, urea>7 mmol·L(-1), respiratory rate≥30 breaths·min(-1), blood pressure
ISSN:0903-1936
1399-3003
DOI:10.1183/09031936.00113612